학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 141건 | 목록
1~20
Academic Journal
Coleman N; Trinity College Dublin Dublin Ireland.; Wei Z; Dana-Farber Cancer Institute Boston, MA United States.; Iafrate AJ; Massachusetts General Hospital Boston, MA United States.; Zwiebel JA; National Cancer Institute Bethesda, MD United States.; Sharon E; Dana-Farber Cancer Institute Boston, MA United States.; Gray RJ; Dana-Farber Cancer Institute Boston, MA United States.; Wang V; Dana-Farber Cancer Institute United States.; McShane LM; National Institutes of Health Bethesda, MD United States.; Rubinstein LV; National Institutes of Health, National Cancer Institute Bethesda, MD United States.; Patton DR; National Cancer Institute Bethesda, MD United States.; Williams PM; Frederick National Laboratory for Cancer Research United States.; Hamilton SR; City Of Hope National Medical Center Irwindale, California United States.; Takebe N; OU Health Stephenson Cancer Center Oklahoma City, Oklahoma United States.; Williams T; St. Luke's Mountain States Tumor Institute Boise, ID United States.; Croley JJ; Saint Joseph Hospital East United States.; Onitilo AA; Wisconsin NCORP Weston, Wisconsin United States.; Tricoli JV; National Cancer Institute Rockville, MD United States.; Cheng J; Broad Institute United States.; Karlovich C; Frederick National Laboratory for Cancer Research Frederick, MD United States.; Conley BA; National Cancer Institute Northport, MI United States.; Arteaga CL; The University of Texas Southwestern Medical Center Dallas, Texas United States.; Harris L; National Cancer Institute Rockville, MD United States.; O'Dwyer PJ; University of Pennsylvania Philadelphia, PA United States.; Hong DS; The University of Texas MD Anderson Cancer Center Houston, Texas United States.; Chen AP; National Cancer Institute Bethesda, MD United States.; Flaherty KT; Massachusetts General Hospital Cancer Center Boston, MA United States.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Janku F; Division of Cancer Medicine, Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX.; Jegede OA; ECOG-ACRIN Biostatistics Center, Dana-Farber Cancer Institute, Boston, MA.; Puhalla SL; University of Pittsburgh Hillman Cancer Center, Pittsburgh, PA.; Konstantinopoulos PA; Division of Gynecologic Oncology, Dana-Farber Cancer Institute, Boston, MA.; Meric-Bernstam F; Division of Cancer Medicine, Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, TX.; Zwiebel JA; Division of Cancer Treatment and Diagnosis, Investigational Drug Branch, National Cancer Institute, Bethesda, MD.; Gray RJ; ECOG-ACRIN Biostatistics Center, Dana-Farber Cancer Institute, Boston, MA.; Wang XV; ECOG-ACRIN Biostatistics Center, Dana-Farber Cancer Institute, Boston, MA.; McShane LM; Division of Cancer Treatment and Diagnosis, Biometric Research Program, National Cancer Institute, Bethesda, MD.; Rubinstein LV; Division of Cancer Treatment and Diagnosis, Biometric Research Program, National Cancer Institute, Bethesda, MD.; Patton DR; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, MD.; Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD.; Hamilton SR; City of Hope National Medical Center, Duarte, CA.; Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Ghani S; University of Oklahoma Health Science Center, Oklahoma City, OK.; Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX.; Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA.; Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Academic Journal
Zauderer MG; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY and Westchester Medical Center and New York Medical College, Valhalla, NY.; Jegede O; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.; Jackman DM; Dana Farber Cancer Institute, Boston, MA.; Zwiebel JA; Investigational Drug Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Gray RJ; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.; Wang V; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.; McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Patton DR; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, MD.; Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD.; Hamilton SR; City of Hope National Medical Center, Duarte, CA.; Takebe N; Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Huang R; Brigham and Women's Hospital, Boston, MA.; Carrillo JA; University of California, Irvine, CA.; Brenner AJ; University of Texas Health Sciences Center, San Antonio, TX.; Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX.; Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA.; Chen AP; Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Academic Journal
Gien LT; Odette Cancer Centre-Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Song Z; Dana Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, MA.; Poklepovic A; Virginia Commonwealth University/Massey Cancer Center, Richmond, VA.; Collisson EA; Fred Hutchinson Cancer Center, Seattle, WA.; Zwiebel JA; Investigational Drug Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Gray RJ; Dana Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, MA.; Wang V; Dana Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, MA.; McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Patton DR; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, MD.; Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD.; Deceased.; Hamilton SR; City of Hope National Medical Center, Duarte, CA.; Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX.; Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA.; Chen AP; Early Clinical Trials Development Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Flaherty KT; Massachusetts General Hospital Cancer Center; Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Academic Journal
Flaherty KT; Massachusetts General Hospital, Boston, MA, USA.; Gray R; Dana Farber Cancer Institute ECOG-ACRIN Biostatistics Center, Boston, MA, USA.; Chen A; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.; Li S; Dana Farber Cancer Institute ECOG-ACRIN Biostatistics Center, Boston, MA, USA.; Patton D; Center for Biomedical Informatics and Information Technology, National Cancer Institute, NIH, Bethesda, MD, USA.; Hamilton SR; University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Mitchell EP; Thomas Jefferson University Hospital, Philadelphia, PA, USA.; Iafrate AJ; Massachusetts General Hospital, Harvard University, Boston, MA, USA.; Sklar J; Yale University, New Haven, CT, USA.; Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.; McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.; Rubinstein LV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.; Sims DJ; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Routbort M; University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Coffey B; Center for Biomedical Informatics and Information Technology, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Fu T; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Zwiebel JA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.; Little RF; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.; Marinucci D; ECOG-ACRIN Cancer Research Group, Philadelphia, PA, USA.; Catalano R; ECOG-ACRIN Cancer Research Group, Philadelphia, PA, USA.; Magnan R; ECOG-ACRIN Cancer Research Group, Boston, MA, USA.; Kibbe W; Center for Biomedical Informatics and Information Technology, National Cancer Institute, NIH, Bethesda, MD, USA.; Weil C; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.; Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.; Alexander B; Radiation Oncology, Dana Farber Cancer Institute, Boston, MA, USA.; Kumar S; Mayo Clinic, Rochester, MN, USA.; Schwartz GK; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA.; Meric-Bernstam F; University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lih CJ; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; McCaskill-Stevens W; Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, MD, USA.; Caimi P; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA.; Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.; Datta V; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.; Arteaga CL; University of Texas Southwestern Simmons Cancer Center, Dallas, TX, USA.; Abrams JS; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.; Comis R; ECOG-ACRIN Cancer Research Group, Philadelphia, PA, USA.; O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA, USA.; Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, MD, USA.
Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE
Academic Journal
Wisinski KB; Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, WI.; Flamand Y; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.; Wilson MA; Department of Oncology, Division of Hematology/Medical Oncology, St Luke's University Health Network, Easton, PA.; Luke JJ; Division of Hematology/Oncology, University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA.; Tawbi HA; MD Anderson Cancer Center, Houston, TX.; Hong F; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.; Mitchell EP; Thomas Jefferson University Hospital, Philadelphia, PA.; Zwiebel JA; Investigational Drug Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Chen H; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Gray RJ; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.; Li S; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.; McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Patton D; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, MD.; Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD.; Hamilton SR; Department of Pathology, City of Hope, Duarte, CA.; Behrens RJ; Iowa-Wide Oncology Research Association NCORP, Des Moines, IA.; Pennington KP; Fred Hutchinson Cancer Research Center, Seattle, WA.; Conley BA; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Arteaga CL; University of Texas Southwestern Medical Center, Dallas, TX.; Harris LN; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA.; Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Flaherty KT; Massachusetts General Hospital, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Academic Journal
Bedard PL; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Li S; E-A Biostatistical Center, Boston, MA.; Wisinski KB; University of Wisconsin Carbone Cancer Center, Madison, WI.; Yang ES; University of Alabama-Birmingham, Birmingham, AL.; Limaye SA; Kokilaben Dhirubhai Ambani Hospital, Mumbai, India (Current).; Mitchell EP; Thomas Jefferson University Hospital, Philadelphia, PA.; Zwiebel JA; Investigational Drug Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Moscow JA; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Gray RJ; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.; Wang V; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.; McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Patton DR; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, MD.; Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD.; Hamilton SR; City of Hope National Medical Center, Duarte, CA.; Conley BA; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Arteaga CL; UT Southwestern Simmons Cancer Cancer Center, Dallas, TX.; Harris LN; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA.; Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Flaherty KT; Massachusetts General Hospital, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Academic Journal
Science. 241:1349-1352
Academic Journal
Cristofaro JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, Maryland, USA.; Ansher SS; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, Maryland, USA.; Zwiebel JA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, Maryland, USA.; Ivy P; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, Maryland, USA.; Conley B; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, Maryland, USA.; Abrams JS; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, Maryland, USA.; Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, Bethesda, Maryland, USA.; Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland, USA.
Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Academic Journal
Krop IE; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Jegede OA; Dana-Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, MA.; Grilley-Olson JE; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.; Lauring JD; Johns Hopkins School of Medicine, Baltimore, MD.; Mitchell EP; Thomas Jefferson University, Philadelphia, PA.; Zwiebel JA; National Cancer Institute, Bethesda, MD.; Gray RJ; Dana-Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, MA.; Wang V; Dana-Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, MA.; McShane LM; National Cancer Institute, Bethesda, MD.; Rubinstein LV; National Cancer Institute, Bethesda, MD.; Patton D; National Cancer Institute, Bethesda, MD.; Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD.; Hamilton SR; City of Hope Comprehensive Cancer Center, Duarte, CA.; Kono SA; Colorado Permanente Medical Group, Lone Tree, CO.; Ford JM; Stanford University, Stanford, CA.; Garcia AA; Louisiana State University Health Science Center, New Orleans, LA.; Sui XD; Providence Regional Cancer System, Lacey, WA.; Siegel RD; Bon Secours St Francis Hospital, Greenville, SC.; Slomovitz BM; University of Miami, Miami, FL.; Conley BA; National Cancer Institute, Bethesda, MD.; Arteaga CL; University of Texas Southwestern Medical Center, Dallas, TX.; Harris LN; National Cancer Institute, Bethesda, MD.; O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA.; Chen AP; National Cancer Institute, Bethesda, MD.; Flaherty KT; Massachusetts General Hospital, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Jhaveri KL; Department of Medicine, Memorial Sloan-Kettering Center, New York, USA. Electronic address: jhaverik@mskcc.org.; Wang XV; Biostatistics, E-A Biostatistical Center, Boston, USA.; Makker V; Gynecologic Medical Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, USA.; Luoh SW; Knight Cancer Institute, Oregon Health Science University, Portland, USA.; Mitchell EP; Medical Oncology, Thomas Jefferson University, Philadelphia, USA.; Zwiebel JA; Investigational Drug Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, USA.; Sharon E; Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA.; Gray RJ; Department of Biostatistics, Dana Farber Cancer Institutes, Boston, USA.; Li S; Department of Biostatistics, Dana Farber Cancer Institutes, Boston, USA.; McShane LM; Biometric Research Branch, National Cancer Institute, Bethesda, USA.; Rubinstein LV; Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institute of Health, Bethesda, USA.; Patton D; Center for Biomedical, Informatics & Information Technology, National Cancer Institute, Bethesda, USA.; Williams PM; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, USA.; Hamilton SR; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, USA.; Conley BA; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, USA.; Arteaga CL; Department of Internal Medicine, University of Texas Southwestern, Dallas, USA.; Harris LN; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, USA.; O'Dwyer PJ; University of Pennsylvania, Philadelphia, USA.; Chen AP; CTEP, National Cancer Institute, Bethesda, USA.; Flaherty KT; Cancer Center, Massachusetts General Hospital, Boston, USA.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE; PubMed not MEDLINE
Academic Journal
Cleary JM; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. jcleary@partners.org.; Wang V; Dana-Farber Cancer Institute, Boston, Massachusetts.; Heist RS; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; Kopetz ES; University of Texas MD Anderson Cancer Center, Houston, Texas.; Mitchell EP; Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.; Zwiebel JA; Investigational Drug Branch, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland.; Kapner KS; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Chen HX; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland.; Li S; Dana-Farber Cancer Institute, Boston, Massachusetts.; Gray RJ; Dana-Farber Cancer Institute, Boston, Massachusetts.; McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland.; Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland.; Patton DR; Center for Biomedical Informatics and Information Technology, NCI, Bethesda, Maryland.; Meric-Bernstam F; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.; Dillmon MS; Harbin Clinic Medical Oncology and Clinical Research. Rome, Georgia.; Williams PM; Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Hamilton SR; University of Texas MD Anderson Cancer Center, Houston, Texas.; Conley BA; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland.; Aguirre AJ; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; O'Dwyer PJ; University of Pennsylvania, Philadelphia, Pennsylvania.; Harris LN; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland.; Arteaga CL; UT Southwestern Medical Center, Dallas, Texas.; Chen AP; Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland.; Flaherty KT; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Abrams JS; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD 20852, USA. abramsj@mail.nih.gov; Mooney MM; Zwiebel JA; Korn EL; Friedman SH; Finnigan SR; Schettino PR; Denicoff AM; Kruhm MG; Montello M; Misra RR; Ansher SS; DiPiazza KJ; Souhan EM; Wickerham DL; Giantonio BJ; O'Donnell RT; Sullivan DM; Soto NI; Fleming GF; Prindiville SA; Petryshyn RA; Hautala JA; Grad O; Zuckerman BL; Meyer RM; Yao JC; Baker LA; Buckner JC; Hortobagyi GN; Doroshow JH
Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE
Academic Journal
Kalinsky K; Department of Medicine, Columbia University Irving Medical Center, New York, New York.; Now with Winship Cancer Institute at Emory University, Atlanta, Georgia.; Hong F; Department of Biostatistics, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; McCourt CK; Department of Obstetrics and Gynecology, Washington University School of Medicine in St Louis, St Louis, Missouri.; Sachdev JC; Department of Medicine, TGen/HonorHealth Research Institute, Scottsdale, Arizona.; Mitchell EP; Department of Medicine, Thomas Jefferson University Health, Philadelphia, Pennsylvania.; Zwiebel JA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Doyle LA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Li S; Department of Biostatistics, Dana-Farber Cancer Institute-ECOG (Eastern Cooperative Oncology Group)-ACRIN (American College of Radiology Imaging Network) Biostatistics Center, Boston, Massachusetts.; Gray RJ; Department of Biostatistics, Dana-Farber Cancer Institute-ECOG (Eastern Cooperative Oncology Group)-ACRIN (American College of Radiology Imaging Network) Biostatistics Center, Boston, Massachusetts.; Rubinstein LV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Patton D; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Williams PM; Division of Cancer Therapeutics and Diagnosis, Molecular Characterization and Assay Development Laboratory, Leidos, Frederick, Maryland.; Hamilton SR; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston.; Department of Pathology, City of Hope National Medical Center, Duarte, California.; Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; O'Dwyer PJ; Department of Medicine, University of Pennsylvania, Philadelphia.; Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Arteaga CL; Department of Medicine, University of Texas Southwestern Simmons Cancer Center, Dallas.; Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Flaherty KT; Department of Medicine, Massachusetts General Hospital, Boston.
Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE
Academic Journal
Flaherty KT; Massachusetts General Hospital, Boston, MA.; Gray RJ; ECOG-ACRIN Cancer Research Group Biostatistics Center, Dana Farber Cancer Institute Boston, MA.; Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.; Li S; ECOG-ACRIN Cancer Research Group Biostatistics Center, Dana Farber Cancer Institute Boston, MA.; McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.; Patton D; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD.; Hamilton SR; University of Texas MD Anderson Cancer Center, Houston, TX.; Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD.; Iafrate AJ; Massachusetts General Hospital, Boston, MA.; Harvard University, Boston, MA.; Sklar J; Yale University, New Haven, CT.; Mitchell EP; Thomas Jefferson University Hospital, Philadelphia, PA.; Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.; Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.; Sims DJ; Frederick National Laboratory for Cancer Research, Frederick, MD.; Coffey B; Center for Biomedical Informatics and Information Technology, Frederick National Laboratory for Cancer Research, Frederick, MD.; Fu T; Frederick National Laboratory for Cancer Research, Frederick, MD.; Routbort M; University of Texas MD Anderson Cancer Center, Houston, TX.; Zwiebel JA; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.; Rubinstein LV; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.; Little RF; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.; Arteaga CL; University of Texas Southwestern Simmons Cancer Center, Dallas, TX.; Comis R; ECOG-ACRIN Cancer Research Group, Philadelphia, PA.; Deceased.; Abrams JS; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.; O'Dwyer PJ; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.; Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Salama AKS; Duke University, Durham, NC.; Li S; ECOG-ACRIN Biostatistical Center, Boston, MA.; Macrae ER; Columbus Oncology and Hematology Associates, Columbus, OH.; Park JI; Medical College of Wisconsin, Milwaukee, WI.; Mitchell EP; Thomas Jefferson University Hospital, Philadelphia, PA.; Zwiebel JA; Investigational Drug Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Chen HX; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Gray RJ; ECOG-ACRIN Biostatistical Center, Boston, MA.; McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Patton D; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, MD.; Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD.; Hamilton SR; MD Anderson Cancer Center, Houston, TX.; Armstrong DK; Johns Hopkins University, Baltimore, MD.; Conley BA; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Arteaga CL; University of Texas Southwestern Medical Center, Dallas, TX.; Harris LN; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA.; Chen AP; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Flaherty KT; Massachusetts General Hospital, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Chae YK; Northwestern University, Chicago, IL.; Hong F; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.; Vaklavas C; University of Alabama at Birmingham, Birmingham, AL.; Huntsman Cancer Institute of the University of Utah, Salt Lake City, UT.; Cheng HH; Seattle Cancer Center Alliance, Seattle, WA.; Hammerman P; Dana Farber Cancer Institute, Boston, MA.; Mitchell EP; Thomas Jefferson University Hospital, Philadelphia, PA.; Zwiebel JA; Investigational Drug Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Ivy SP; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Gray RJ; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.; Li S; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.; McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Patton D; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, MD.; Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD.; Hamilton SR; MD Anderson Cancer Center, Houston, TX.; Mansfield A; Mayo Clinic, Rochester, MN.; Conley BA; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Arteaga CL; University of Texas Southwestern Medical Center, Dallas, TX.; Harris LN; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA.; Chen AP; Investigational Drug Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.; Flaherty KT; Massachusetts General Hospital, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Klisovic RB; Division of Hematology, Department of Medicine.; Blum W; Liu Z; Xie Z; Kefauver C; Huynh L; Zwiebel JA; Devine SM; Byrd JC; Grever MR; Chan KK; Marcucci G
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Zwiebel, JA
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어